Close
Help




JOURNAL

Drug Target Insights

Microscopic Colitis is Associated with Several Concomitant Diseases

Submit a Paper


Drug Target Insights 2013:7 19-25

Rapid Communication

Published on 11 Aug 2013

DOI: 10.4137/DTI.S12109


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Drug Target Insights

Abstract

Microscopic colitis (MC) is a disease with intestinal mucosal inflammation causing diarrhea, affecting predominantly middle-aged women. The etiology is unknown, but increased prevalence of autoimmune diseases in these patients has been described, although not compared with controls or adjusted for confounding factors. The aim of this study was to examine the prevalence of common diseases in patients with MC and controls from the general population. Hypertension, rheumatoid arthritis, asthma or bronchitis, ischemia, and diabetes mellitus were more prevalent in patients than in controls. The prevalence of gastric ulcer and cancer did not differ between the groups. Besides corticosteroids, many patients were also being treated with proton pump inhibitors, antidepressant drugs, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists, statins, thyroid hormones, and beta-blockers. More patients than controls were former or current smokers (72.5% versus 57.7%). Thus, MC patients have an increased prevalence of several diseases, not only of autoimmune origin.



Downloads

PDF  (467.77 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Drug Target Insights
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
Dr Bodil Ohlsson (Lund University, Sweden)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube